A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2017
At a glance
- Drugs PDC 1421 (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Sponsors BioLite Inc
- 15 Apr 2017 Last checked against ClinicalTrials.gov record.
- 02 Feb 2017 Planned End Date changed from 1 Dec 2017 to 1 Mar 2018.
- 02 Feb 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Oct 2017.